RETA 5 mg – Advanced Research Peptide for Laboratory Use
RETA 5 mg is a high-purity research peptide designed exclusively for laboratory studies, modeled after Tirzepatide, a dual GLP-1 and GIP receptor agonist. This compound is intended for scientific investigations related to obesity, type 2 diabetes, and metabolic regulation.
With its dual-action mechanism targeting GLP-1 and GIP receptors, RETA 5 mg is a valuable tool for researchers exploring innovative metabolic therapies. It is of particular interest for studies on glycemic control, appetite regulation, and fat metabolism.
Applications of RETA 5 mg in Laboratory Research
RETA 5 mg is strictly for laboratory research and may be used in:
- Studies on obesity, metabolic syndrome, and type 2 diabetes
- Investigations into GLP-1 and GIP receptor agonist mechanisms
- Research on incretin-based peptides
- Analysis of fat and carbohydrate metabolism
Potential Research Outcomes
Studies on similar compounds suggest potential areas of exploration for RETA 5 mg, including:
- Appetite suppression mechanisms
- Glucose level regulation
- Prolonged satiety effects
- Metabolic parameter improvements
- Dual GLP-1 and GIP receptor activation
Product Specifications
- Name: RETA
- Active Substance Content: 5 mg
- Form: Lyophilized powder
- Purity: ≥ 98% (HPLC)
- Type: Tirzepatide-like research peptide
- Synonyms: GLP-1/GIP agonist peptide
- Category: Metabolic research peptides
⚠️ Legal and Safety Information
RETA 5 mg is classified as a chemical reagent for research purposes only, permitted for use in laboratory settings by qualified personnel within the European Union. It is not a dietary supplement, medicine, or food product and is not intended for human or animal consumption.
Why Choose RETA 5 mg for Research?
- Inspired by a leading molecule in metabolic research
- Exceptional purity (≥ 98%)
- Versatile applications in metabolic and glucose regulation studies
- Premium-grade peptide for laboratory investigations
Reviews
There are no reviews yet.